Sutro Biopharma STRO
NASDAQ STRO
$20.07 -0.47 (-2.29%)
As of: Sep 4, 2026 · 3:59 PM EDT

Sutro Biopharma (STRO) Price to Earnings (2018 - 2026)

Analysis

Sutro Biopharma (STRO) Price to Earnings (2018 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Sutro Biopharma 334.33 Mn 169.99 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -14.28
Dec 31, 2025 -14.81
Sep 30, 2025 -1.30
Jun 30, 2025 -5.26
Mar 31, 2025 -0.84
Dec 31, 2024 -2.10
Sep 30, 2024 -5.84
Jun 30, 2024 -5.00
Mar 31, 2024 -6.06
Dec 31, 2023 8.43
Sep 30, 2023 -4.29
Jun 30, 2023 -7.30
Mar 31, 2023 -5.55
Dec 31, 2022 -13.43
Sep 30, 2022 -15.56
Jun 30, 2022 -9.75
Mar 31, 2022 -9.86
Dec 31, 2021 -18.08
Sep 30, 2021 -28.28
Jun 30, 2021 -139.43